PremiumThe FlyEstrella Immunopharma doses first patient in second cohort of STARLIGHT-1 trial Estrella Immunopharma completes first dose cohort in STARLIGHT trial Estrella Immunopharma initiated with a Buy at D. Boral Capital PremiumThe FlyEstrella Immunopharma names Hong Zhang as chairperson Estrella Immunopharma Unveils Updated Investor Presentation Estrella Immunopharma Approves $1 Million Stock Buyback Program